Enhanced Energy Expenditure via NNMT Inhibition : In preclinical models, 5-Amino-1MQ increased whole-body metabolic rate by redirecting cellular resources away from fat storage and toward active ATP production
Comparative genomic mapping implicates LRRK2 for intellectual disability and autism at 12q12, and HDHD1, as well as PNPLA4, for X-linked intellectual disability at Xp22.31
- 5-Amino-1MQ is studied in research models involving NNMT pathway activity, NAD+-adjacent metabolism, adipocyte biology, methylation-related signaling, cellular energy regulation, and body-composition pathway research
Special considerations and populations Certain individuals may need protocol modifications based on specific circumstances or characteristics
Can I receive multiple IM injections in one session
Frequency: The frequency of administration is typically once daily, although the available data is limited